Computational Screening of Repurposed Drugs Targeting SARS-CoV-2 Main Protease by Molecular Docking

September 2022 in “ Sudan Journal of Medical Sciences ”

Hui-Yin Yow, Yin-Quan Tang

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on knepublishing.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19

70 citations , July 2020 in “Pharmacological Reports”

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19

4 citations , May 2020

Cepharanthine could be a strong antiviral against COVID-19.